HANSOH PHARMAC Valuation
| 3KY Stock | EUR 2.00 0.02 1.01% |
Based on Macroaxis valuation methodology, the entity appears to be overvalued. HANSOH PHARMAC HD retains a regular Real Value of €1.8 per share. The prevalent price of the entity is €2.0. Our model calculates the value of HANSOH PHARMAC HD from inspecting the entity fundamentals such as operating margin of 0.28 %, and Return On Asset of 0.063 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that HANSOH PHARMAC's price fluctuation is very risky at this time. Calculation of the real value of HANSOH PHARMAC HD is based on 3 months time horizon. Increasing HANSOH PHARMAC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the HANSOH stock is determined by what a typical buyer is willing to pay for full or partial control of HANSOH PHARMAC HD 00001. Since HANSOH PHARMAC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of HANSOH Stock. However, HANSOH PHARMAC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0 | Real 1.8 | Hype 2.0 | Naive 2.08 |
The real value of HANSOH Stock, also known as its intrinsic value, is the underlying worth of HANSOH PHARMAC HD Company, which is reflected in its stock price. It is based on HANSOH PHARMAC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of HANSOH PHARMAC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of HANSOH PHARMAC HD 00001 helps investors to forecast how HANSOH stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of HANSOH PHARMAC more accurately as focusing exclusively on HANSOH PHARMAC's fundamentals will not take into account other important factors: HANSOH PHARMAC Total Value Analysis
HANSOH PHARMAC HD 00001 is presently estimated to have takeover price of 0 with market capitalization of 11.47 B, debt of 92.75 M, and cash on hands of 13.73 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the HANSOH PHARMAC fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 11.47 B | 92.75 M | 13.73 B |
HANSOH PHARMAC Investor Information
About 82.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 8th of September 2022. Based on the measurements of operating efficiency obtained from HANSOH PHARMAC's historical financial statements, HANSOH PHARMAC HD 00001 is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.HANSOH PHARMAC Asset Utilization
One of the ways to look at asset utilization of HANSOH is to check how much profit was generated for every dollar of assets it reports. HANSOH PHARMAC HD harnesses its resources almost 0.063 (percent), realizing 0.063 cents for each euro of resources held by the entity. An expanding asset utilization attests that the company is being more productive with each euro of resources it retains. Simply put, asset utilization of HANSOH PHARMAC shows how productive it operates for each euro spent on its resources.HANSOH PHARMAC Ownership Allocation
HANSOH PHARMAC HD 00001 has a total of 5.92 Billion outstanding shares. HANSOH PHARMAC HD retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.92 (percent) of HANSOH PHARMAC outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the entity is less than the current market value, you may not be able to make money on it.HANSOH PHARMAC Profitability Analysis
The company reported the revenue of 9.97 B. Net Income was 2.57 B with profit before overhead, payroll, taxes, and interest of 9.06 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates HANSOH PHARMAC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in HANSOH PHARMAC and how it compares across the competition.
About HANSOH PHARMAC Valuation
The stock valuation mechanism determines HANSOH PHARMAC's current worth on a weekly basis. Our valuation model uses a comparative analysis of HANSOH PHARMAC. We calculate exposure to HANSOH PHARMAC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of HANSOH PHARMAC's related companies.Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals and active pharmaceutical ingredients in the Peoples Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd. HANSOH PHARMAC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11645 people.
8 Steps to conduct HANSOH PHARMAC's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates HANSOH PHARMAC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct HANSOH PHARMAC's valuation analysis, follow these 8 steps:- Gather financial information: Obtain HANSOH PHARMAC's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine HANSOH PHARMAC's revenue streams: Identify HANSOH PHARMAC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research HANSOH PHARMAC's industry and market trends, including the size of the market, growth rate, and competition.
- Establish HANSOH PHARMAC's growth potential: Evaluate HANSOH PHARMAC's management, business model, and growth potential.
- Determine HANSOH PHARMAC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate HANSOH PHARMAC's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for HANSOH Stock analysis
When running HANSOH PHARMAC's price analysis, check to measure HANSOH PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HANSOH PHARMAC is operating at the current time. Most of HANSOH PHARMAC's value examination focuses on studying past and present price action to predict the probability of HANSOH PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HANSOH PHARMAC's price. Additionally, you may evaluate how the addition of HANSOH PHARMAC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |